Department of Health and Social Care

The National Health Service’s three-year delivery plan for maternity and neonatal services recognises that listening and responding to all women, their partners and families, is an essential part of enabling and delivering safe and high-quality care. There are multiple initiatives in place that recognise and involve the role of fathers and other parents. These initiatives include:

- ensuring that fathers’ perspectives shape improvements to services and care, through Maternity and Neonatal Voice Partnerships;

- encouraging fathers’ involvement in the care for their babies in neonatal units, through Family Integrated Care, helping to strengthen the parent-infant bond and infant health outcomes;

- providing evidence-based assessments and support for partners, including fathers, through Specialist Perinatal Mental Health Services. This has helped 5% to 10% of fathers experiencing mental health conditions during the perinatal period;

- health visiting services that are parent focussed and which include both mothers and fathers, and which are including in perinatal mental health support; and

- the Department announcing £126 million for the continuation of the Family Hubs and Start for Life programme for 2025/26 in 75 local authorities with high levels of deprivation in January 2025. This includes £36.5 million for bespoke perinatal mental health and parent-infant relationship support, including for fathers.

Work is progressing at pace to map functions, appraise options, and inform decision making on where NHS England’s functions will best sit.

There are important choices to be made, and ministers and senior Department officials will work with the new executive team in NHS England, led by Sir Jim Mackey, to ensure the new joint centre will operate more efficiently, cut out unnecessary bureaucracy, and empower those working on the frontline.

In taking forward the work, we will ensure that we continue to evaluate impacts of all kinds.

The 10-Year Health Plan will deliver the three big shifts our National Health Service needs to be fit for the future: from hospital to community; from analogue to digital; and from sickness to prevention. All of these are relevant to improving respiratory health in all parts of the country.

More tests and scans delivered in the community will allow earlier diagnosis, better joint working between services, and greater use of apps and wearable technology will all help people manage their long-term conditions, including respiratory conditions, closer to home. Earlier diagnosis of conditions will help prevent deterioration and improve survival rates. Taking action to reduce the causes of the biggest killers, such as enabling a smoke free generation, can further help prevent lung conditions.

The Government understands that more needs to be done to improve outcomes for all patients with prostate cancer.

Currently, the UK National Screening Committee (UK NSC) does not recommend a national prostate cancer screening programme due to the limitations of the current best test, the Prostate Specific Antigen test, which may lead to overdiagnosis and overtreatment of cancers that would not have caused harm during a man’s lifetime. However, the UK NSC is undertaking a comprehensive evidence review to assess six potential approaches to targeted screening for those at higher risk of developing prostate cancer. Recommendations will be published upon the conclusion of this review.

In addition, the Government has invested £16 million in the £42 million United Kingdom-wide TRANSFORM trial, led by Prostate Cancer UK, which aims to identify new ways of detecting prostate cancer at an earlier stage, including in men without symptoms.

Improving access to timely treatment and care remains a key priority for all cancer types, including prostate cancer. The forthcoming National Cancer Plan will set out further measures to improve cancer outcomes, including efforts to reduce waiting times and improve cancer treatment for all patients, including for prostate cancer.

The National Health Service website provides advice on how to protect your eyes in the sun. It recommends avoiding looking directly at the sun, as this can cause permanent eye damage, and advises people to wear sunglasses with the appropriate ultraviolet protection. Further information can be found on the NHS page on sun and sunscreen safety, at the following link:

https://www.nhs.uk/live-well/seasonal-health/sunscreen-and-sun-safety/

Sun exposure can increase the risk of eye cancer. The Department is currently seeking views and ideas to inform the development of the National Cancer Plan for England, to meet the health mission goal to reduce the lives lost to the biggest killers. The consultation materials are available at the following link:

https://www.gov.uk/government/calls-for-evidence/shaping-the-national-cancer-plan/shaping-the-national-cancer-plan

The Department routinely engages with partners from overseas to share knowledge and best practice, to support strategy and policy development across the Department.

As part of the 10-Year Health Plan engagement exercise, we have been working with international experts to understand different countries’ approaches to delivering healthcare, and the three shifts at the centre of the plan, from hospital to community, from analogue to digital, and from sickness to prevention. In March, the Department jointly hosted two ministerial led roundtables with WHO EURO and Kings College London, where international experts shared experiences of implementing the three shifts. Attendees from around the world included former ministers, government officials, academics, and health system experts, to provide expert insight into international best practice.

We are committed to improving care and support for people with myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). We recognise how devastating the symptoms can be, and the significant impact they can have on patients and their families.

We aim to publish the final ME/CFS delivery plan by the end of June 2025, where one of the key themes is bettering the lives of those living with this debilitating disease, as well as boosting research, and improving attitudes and education.

The responses to the interim delivery plan consultation, along with continued close engagement with the Government, National Health Service and external stakeholders, will inform the development of the final ME/CFS delivery plan, which will include actions to improve quality of life.

NHS Blood and Transplant (NHSBT) is responsible for blood donation in England. NHSBT tests for haemoglobin levels rather than iron levels ahead of blood donation. In the last 12 months, 169,436 donations were deferred due to low haemoglobin levels, and 4,527 donations were deferred due to the donor’s recent travel to other countries where there is a risk of transmitting specific diseases to recipients via the blood donated.

Information for donors on eligibility to donate, including on haemoglobin levels and donation after travel, is available at the following link:

www.blood.co.uk

Working under the UK Rare Diseases Framework, the Government is committed to improving the lives of those living with rare diseases, such as sickle cell disorder. This framework sets out four priorities collaboratively developed with the rare disease community, which include increasing awareness of rare diseases among healthcare professionals.

NHS England has launched several activities to improve staff knowledge and training aimed at healthcare professionals, including developing the ACT NOW campaign to improve awareness of frontline staff of what to do when people attend hospital in a sickle cell crisis, providing support to specialist staff for sickle cell and thalassemia through the Haemoglobinopathy Coordinating Centre network, and developing free e-learning to help staff, including those in accident and emergency, haematology, and ambulance services, to identify signs of a sickle cell crisis. Further information on the ACT NOW campaign is available at the following link:

https://www.england.nhs.uk/london/a-c-t-n-o-w-sickle-cell-acronym-pilot/

NHS England is working with clinicians and people with sickle cell disorder in Manchester to understand how to help people to better manage their disorder. The learning from this pilot will be shared nationally, to support others to embed a similar approach to care, that reflects the needs of their local populations.

NHS Blood and Transplant (NHSBT) is responsible for blood donation in England.

NHSBT does not collect the reasons for short notice, within two days of the appointment, or advanced, further ahead, cancellations either by the donor or by NHSBT. Cancellations can, for example, be due to issues with community venues or due to NHSBT needing to urgently prioritise appointments for donors from those blood groups needed most to meet hospital demand, therefore postponing donors from other blood groups.

In the last 12 months, 109,808 appointments were cancelled at short notice, which is 5.2% of all appointments. 80,264 appointments were cancelled more than two days in advance, which is 3.8% of booked appointments.

Donors may also be deferred during a donation session if they do not meet the eligibility criteria, in place to protect either the donor or recipient’s health. The most common reason for donor deferral is haemoglobin levels.

The National Health Service’s capital settlement for 2024/25 underspend figure is not yet available, although it should be included in the NHS’s annual accounts, which will be published later this year.

£15 million was allocated from capital underspend to replace ageing radiotherapy equipment, as per the answer I gave on 7 April 2025 to Question 41044. Any other spending on radiotherapy equipment was allocated at local level, and we do not hold details on this spend.

£70 million of central capital funding was announced as part of the Autumn Budget in 2024, which will be used to replace 28 machines during 2025/26.

The UK Health Security Agency (UKHSA) and NHS England’s collaborative Tuberculosis (TB): action plan for England, 2021 to 2026 aims to reduce the numbers of cases of TB in non-United Kingdom born individuals migrating to the UK. The plan is available at the following link:

https://www.gov.uk/government/publications/tuberculosis-tb-action-plan-for-england/tuberculosis-tb-action-plan-for-england-2021-to-2026

The UK pre-entry TB screening programme operates in 102 countries and is intended to reduce the importation of TB by screening applicants for long term visas, those greater than six months, from high TB incidence countries, those with more than 40 cases per 100,000 people. People are screened in line with the UK Technical Instructions, which are available at the following link:

https://assets.publishing.service.gov.uk/media/5cd18ae5e5274a34ee7f0275/UK_tuberculosis_technical_instructions_version_7.pdf

Identifying the contacts of people with active TB allows people who would be at high risk of developing the disease to be treated before they become ill. Enhancing contact tracing is a key pillar of the national action plan.

There is also NHS England’s Latent Tuberculosis Infection Testing and Treatment programme, for migrants from high TB burden countries within five years of entry to the UK. In 2023, 34,680 people were tested, an increase of over 100% compared with the pre- pandemic year of 2019.

The UK Health Security Agency (UKHSA) and NHS England’s joint Tuberculosis (TB) Action Plan for England 2021 to 2026 contains actions to encourage the use of new tools to raise awareness of TB in at risk populations and the healthcare workforce. Full details are available at the following link:

https://www.gov.uk/government/publications/tuberculosis-tb-action-plan-for-england/tuberculosis-tb-action-plan-for-england-2021-to-2026.

The UKHSA produced a TB stakeholder communications toolkit which is shared widely at a national and regional level, including by the British Chamber of Commerce. A copy of the toolkit is attached.

The UKHSA continues to raise awareness through national, regional, and specialist media coverage, as well as through community engagement through our regional health protection teams. The UKHSA also commissioned a radio campaign for the Prison Radio Association to raise the prison population’s awareness of TB in England and Wales. Further campaigns are planned.

The NHS England funded Getting It Right First Time TB report, published in March 2025, noted numerous examples of information for awareness-raising for the public from both national and locally developed sources, often in multiple languages. The report is available at the following link:

https://www.england.nhs.uk/wp-content/uploads/2025/03/girft-review-of-tuberculosis-national-report.pdf

The Human Fertilisation and Embryology Authority (HFEA) publishes annual reports on their website which include success rates of in-vitro fertilisation (IVF). The following table shows the success rate of IVF in each of the last ten years for which information is available:

Source: HFEA annual report on fertility treatment and the HFEA dashboard.

Notes:

1. live births for 2019 to 2022 are preliminary and quality assurance processes with clinics have not yet completed; and
2. data excludes embryos that have been previously frozen.

The following table, provided by the Human Fertilisation and Embryology Authority (HFEA), shows the number of human embryos discarded in each of the last ten years for which information is available:

Source: HFEA.

Notes:

1. the data is as recorded by the HFEA on 16 October 2024, so these figures reflect the data on this day and are likely to change over time;
2. data for 2019 to 2022 is preliminary and quality assurance processes with clinics have not yet completed.

There is no further information collected by the HFEA after an embryo is discarded.

The Government is committed to ensuring that anyone with a drug or alcohol problem can access the help and support they need, and we recognise the need for evidenced-based, high-quality treatment.

Local authorities are responsible for assessing local need for alcohol and drug prevention and treatment in their area, and for commissioning services to meet these needs. In addition to the Public Health Grant, in 2025/26 the Department is providing a total of £310 million in additional targeted grants to improve drug and alcohol services and recovery support, which includes housing and employment. Havering Borough Council, of which Romford is a part, will receive £400,302 from this additional grant funding in 2025/26. Further details are available at the following link:

https://www.gov.uk/government/publications/drug-and-alcohol-treatment-and-recovery-funding-2025-to-2026/drug-and-alcohol-treatment-and-recovery-funding-allocations-2025-to-2026

Alongside the funding allocations, the Department also has a range of existing and forthcoming best practice resources and guidance that supports those working in the sector to tailor drug and alcohol treatment services to meet local needs, to improve treatment outcomes. For example, the commissioning quality standard provides guidance to local authorities on how to ensure they have a shared understanding of local need, including the experiences of diverse populations. The commissioning quality standard can be found at the following link:

https://www.gov.uk/government/publications/commissioning-quality-standard-alcohol-and-drug-services

Later this year the Department will also be publishing the United Kingdom’s clinical guidelines on alcohol treatment. The aim of the guidelines is to improve and support good practice to achieve better outcomes for people with alcohol problems.

The Government is committed to ensuring that anyone with a drug or alcohol problem can access the help and support they need, and we recognise the need for evidenced-based, high-quality treatment.

Local authorities are responsible for assessing local need for alcohol and drug prevention and treatment in their area, and for commissioning services to meet these needs. In addition to the Public Health Grant, in 2025/26 the Department is providing a total of £310 million in additional targeted grants to improve drug and alcohol services and recovery support, which includes housing and employment. Havering Borough Council, of which Romford is a part, will receive £400,302 from this additional grant funding in 2025/26. Further details are available at the following link:

https://www.gov.uk/government/publications/drug-and-alcohol-treatment-and-recovery-funding-2025-to-2026/drug-and-alcohol-treatment-and-recovery-funding-allocations-2025-to-2026

Alongside the funding allocations, the Department also has a range of existing and forthcoming best practice resources and guidance that supports those working in the sector to tailor drug and alcohol treatment services to meet local needs, to improve treatment outcomes. For example, the commissioning quality standard provides guidance to local authorities on how to ensure they have a shared understanding of local need, including the experiences of diverse populations. The commissioning quality standard can be found at the following link:

https://www.gov.uk/government/publications/commissioning-quality-standard-alcohol-and-drug-services

Later this year the Department will also be publishing the United Kingdom’s clinical guidelines on alcohol treatment. The aim of the guidelines is to improve and support good practice to achieve better outcomes for people with alcohol problems.

The Human Fertilisation and Embryology Authority (HFEA) has advised that its expert Scientific and Clinical Advances Advisory Committee monitors new studies relating to health outcomes in children conceived by IVF. They last discussed this topic in February 2025, and the associated paper and minutes can be found on the HFEA website, at the following link:

https://www.hfea.gov.uk/about-us/our-authority-committees-and-panels/scientific-and-clinical-advances-advisory-committee-scaac/

HFEA Register data is used in research studies which look at the effects of IVF on the health of children born, with further information about these studies, including details of current and previous projects, available on the HFEA website at the following link:

https://www.hfea.gov.uk/about-us/data-research/

The Department funds dementia research via the National Institute for Health and Care Research (NIHR). The NIHR has invested nearly £11 million of funding to develop new digital approaches for the early detection and diagnosis of dementia via the Invention for Innovation programme.

In addition to NIHR funding, the Government’s Dame Barbara Windsor Dementia Goals programme has provided funding to develop several digital cognitive assessments. For instance, through Innovate UK, the programme has awarded four United Kingdom based companies a share of the £4 million of funding to enable their biomarkers to be tested and validated in a large, diverse group of people, as part of the Bio-Hermes-002 study, which includes a series of tests which look at memory, language, and other cognitive skills.

The programme has also committed to investing £2 million into a quick and easy digital test of patients’ cognitive functions, to be included in the READ-OUT study, which could lead to more accurate diagnoses when administered with blood biomarker tests for Alzheimer’s disease and other causes of dementia. Some of these innovations could support improved diagnosis in the future, if validated for clinical use.

The NIHR welcomes funding applications for research into any aspect of human health and care, including dementia. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. Welcoming applications on dementia to all NIHR programmes enables maximum flexibility both in terms of the amount of research funding a particular area can be awarded, and the type of research which can be funded.

Patients have the right to complain about any aspect of National Health Service care, treatment, or service. The Local Authority Social Services and National Health Service Complaints (England) Regulations 2009 set out the minimum standards NHS organisations must adhere to in respect of their complaint handling arrangements.

The Department has worked closely with the Parliamentary and Health Service Ombudsman on their work to develop the NHS Complaint Standards, which set out how organisations providing services in the NHS should approach complaint handling. The standards place a strong focus on several key aspects of complaint handling and set out practical advice and good practice to help NHS organisations improve.

In addition to these arrangements, the Care Quality Commission has an important role in ensuring NHS providers have an effective and accessible system for handling complaints from service users.

The Human Fertilisation and Embryology Authority (HFEA), the United Kingdom’s fertility sector regulator, has advised that it sets out strict requirements in its Licence Conditions and Code of Practice in relation to the recruitment of donors and the information that must be given to egg donors in advance of donating at United Kingdom licensed fertility clinics, which includes information about the potential immediate or longer-term health risks. The HFEA Code of Practice states that advertising should be designed with regard to the sensitive issues involved in recruiting donors and should follow the Advertising Standards Authority codes.

My Rt Hon. Friend, the Secretary of State for Health and Social Care has not considered additional compulsory listing of health risks on adverts for egg donors.

The Government is carefully considering the valuable work done by the Patient Safety Commissioner and the resulting Hughes Report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex area of work, involving several Government departments, and it is important that we get this right. We will be providing an update to the Patient Safety Commissioner’s report at the earliest opportunity.

The Government is carefully considering the valuable work done by the Patient Safety Commissioner and the resulting Hughes Report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex area of work, involving several Government departments, and it is important that we get this right. We will be providing an update to the Patient Safety Commissioner’s report at the earliest opportunity.

The Department is currently planning to expand the Pharmacy Contraception Service to include the supply of emergency hormonal contraception from October 2025. This means women will have access to the ‘morning-after pill’ free of charge at pharmacies on the National Health Service, which will ensure a consistent offer across the country.

We inherited a broken National Health Service which penalises hard working staff by hampering them with layers of bureaucracy, unclear lines of accountability, and a fragmented, duplicative system. It is a bad use of taxpayers’ money to have two national organisations doing the same jobs. This has left patients worse off and staff unable to do their jobs properly.

Creating a more efficient, leaner centre will free up capacity and help deliver significant savings of hundreds of millions of pounds a year which will be reinvested in frontline services and cutting waiting lists.

We remain committed to fixing the front door of the NHS, building on the progress to date to deliver meaningful reform to establish a modern general practice (GP) at the heart of a neighbourhood health service.

We are investing an additional £889 million in GPs to reinforce the front door of the NHS, bringing total spend on the GP Contract to £13.2 billion in 2025/26. This is the biggest increase in over a decade. The 7.2% boost to the GP Contract is faster than the 5.8% growth to the NHS budget as a whole, helping to reverse the decade-long trend of GPs receiving an ever-decreasing percentage of NHS funding.

GPs will continue to be a core element of the future of the NHS during and after the integration of NHS England into the Department.

Pharmacies play a vital role in our healthcare system, and the Government recognises the integral role they play within our communities, as an easily accessible ‘front door’ to the National Health Service, staffed by highly trained and skilled healthcare professionals.

Community pharmacies are private businesses that provide NHS funded services. Most pharmacies are not directly commissioned or contracted by the NHS, instead contractors apply to gain entry to the NHS pharmaceutical list and if an application is approved, a pharmacy can open and start providing services.

Local authorities are required to undertake a pharmaceutical needs assessment (PNA) every three years to assess whether their population is adequately served by local pharmacies, and must keep these assessments under review. Integrated care boards (ICBs) give regard to the PNAs when reviewing applications from new contractors. Contractors can also apply to open a new pharmacy to offer benefits to patients that were not foreseen by the PNA. If there is a need for a new local pharmacy to open and no contractors apply to open a pharmacy and fill the gap, ICBs can commission a new pharmacy to open outside of the market entry processes and fund the contract from the ICBs’ budgets.

The Pharmacy Access Scheme helps protect access to pharmacies in areas where there are fewer pharmacies and higher health needs, so that no area is left without access to local, physical NHS pharmaceutical services.

In general, despite a reduction in the number of pharmacies in recent years, patient access to pharmacies remains good, and continues to be better in the most deprived areas when compared with the least deprived.

Pharmacies play a vital role in our healthcare system, and the Government recognises the integral role they play within our communities, as an easily accessible ‘front door’ to the National Health Service, staffed by highly trained and skilled healthcare professionals.

Community pharmacies are private businesses that provide NHS funded services. Most pharmacies are not directly commissioned or contracted by the NHS, instead contractors apply to gain entry to the NHS pharmaceutical list and if an application is approved, a pharmacy can open and start providing services.

Local authorities are required to undertake a pharmaceutical needs assessment (PNA) every three years to assess whether their population is adequately served by local pharmacies, and must keep these assessments under review. Integrated care boards (ICBs) give regard to the PNAs when reviewing applications from new contractors. Contractors can also apply to open a new pharmacy to offer benefits to patients that were not foreseen by the PNA. If there is a need for a new local pharmacy to open and no contractors apply to open a pharmacy and fill the gap, ICBs can commission a new pharmacy to open outside of the market entry processes and fund the contract from the ICBs’ budgets.

The Pharmacy Access Scheme helps protect access to pharmacies in areas where there are fewer pharmacies and higher health needs, so that no area is left without access to local, physical NHS pharmaceutical services.

In general, despite a reduction in the number of pharmacies in recent years, patient access to pharmacies remains good, and continues to be better in the most deprived areas when compared with the least deprived.

Pharmacies play a vital role in our healthcare system, and the Government recognises the integral role they play within our communities, as an easily accessible ‘front door’ to the National Health Service, staffed by highly trained and skilled healthcare professionals.

Community pharmacies are private businesses that provide NHS funded services. Most pharmacies are not directly commissioned or contracted by the NHS, instead contractors apply to gain entry to the NHS pharmaceutical list and if an application is approved, a pharmacy can open and start providing services.

Local authorities are required to undertake a pharmaceutical needs assessment (PNA) every three years to assess whether their population is adequately served by local pharmacies, and must keep these assessments under review. Integrated care boards (ICBs) give regard to the PNAs when reviewing applications from new contractors. Contractors can also apply to open a new pharmacy to offer benefits to patients that were not foreseen by the PNA. If there is a need for a new local pharmacy to open and no contractors apply to open a pharmacy and fill the gap, ICBs can commission a new pharmacy to open outside of the market entry processes and fund the contract from the ICBs’ budgets.

The Pharmacy Access Scheme helps protect access to pharmacies in areas where there are fewer pharmacies and higher health needs, so that no area is left without access to local, physical NHS pharmaceutical services.

In general, despite a reduction in the number of pharmacies in recent years, patient access to pharmacies remains good, and continues to be better in the most deprived areas when compared with the least deprived.

We understand that not all patients can or want to use online services. To ensure that such patients are not excluded, the GP Contract is clear that patients should always have the option of telephoning or visiting their practice in person, and all online tools must always be provided in addition to, rather than as a replacement for, other channels for accessing a general practice. Practice receptions should be open so that patients without access to a telephone or online services are in no way disadvantaged.

The 2025/26 GP Contract includes a new requirement for practices to enable online appointment requests throughout the duration of core opening hours, which will ease pressure on phone lines for people who prefer to telephone.

We have concluded the most recent consultation on funding for 2024/25 and 2025/26 with the community pharmacy sector. This deal represents the largest uplift in funding of any part of the National Health Service, over 19% across 2024/25 and 2025/26, and will support community pharmacies in providing clinical services.

As part of this deal, we have increased the fees for ambulatory blood pressure monitoring, the Pharmacy Contraception Service, Pharmacy First Clinical Pathways and Minor Illness, and the New Medicine Service, to support contractors offering these services. We will also expand the Pharmacy Contraception Service and the New Medicine Service.

The Government is committed to expanding the role of pharmacies and better utilising the skills of pharmacists and pharmacy technicians, including by making prescribing part of the services delivered by community pharmacists. NHS England is currently testing how prescribing in community pharmacy could work to inform the commissioning of prescribing from community pharmacies in future.

Lord Darzi’s independent review of the National Health Service, published September 2024, highlighted the severe delays in accessing autism and attention deficit hyperactivity disorder (ADHD) assessments, and that demand for assessments for ADHD and autism has grown significantly in recent years.

It is the responsibility of integrated care board (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including autism and ADHD assessments, in line with relevant National Institute for Health and Care Excellence guidelines.

On 5 April 2023, NHS England published a national framework and operational guidance to help ICBs and the NHS to deliver improved outcomes for children, young people, and adults referred to an autism assessment service. Since publication, NHS England has been supporting systems and services to identify where there are challenges for implementation and how they might overcome these.

NHS England is also working with research organisations to explore evidence-based models that support improved outcomes for those people waiting for an autism assessment.

NHS England has established an ADHD taskforce which is working to bring together those with lived experience with experts from the NHS, education, charity, and justice sectors. The taskforce is working to get a better understanding of the challenges affecting those with ADHD, including timely and equitable access to services and support, with the final report expected in the summer.   In conjunction with the taskforce, NHS England has carried out detailed work to develop an ADHD data improvement plan to inform future service planning.

The responsibility for commissioning primary care services, including National Health Service dentistry, to meet the needs of the local population has been delegated to the integrated care boards (ICBs) across England. The ICBs have been asked to start making extra urgent dental appointments available from April 2025. The Bath and North East Somerset, Swindon and Wiltshire ICB is expected to deliver 13,990 additional urgent dental appointments as part of the scheme.

The methodology used to determine how to allocate the 700,000 appointments across the ICBs has considered factors including unmet need, population size, and projected contract delivery at an ICB level in 2024/25. Details can be found in the letter sent to the ICBs on 21 February 2025 in Annex A, which is available at the following link:

https://www.england.nhs.uk/long-read/arrangements-for-nhs-urgent-primary-dental-care-during-2025-26-and-confirmation-of-the-closure-of-the-new-patient-premium-scheme/

The current community audiology service in Harrow East requires a referral from a healthcare professional to access the service. The North West London Integrated Care Board is examining how this service could be developed, in the light of recent guidance around increasing self-referral to services such as audiology, in a manner that meets the needs of the population and which fits sustainably within the funding available for this service.

Free National Health Service dental care is available to people who meet the following criteria:

- under 18 years old, or under 19 years old and in full-time education;

- pregnant, or have had a baby in the previous 12 months;

- being treated in an NHS hospital and the treatment is carried out by the hospital dentist, although patients may have to pay for any dentures or bridges; or

- receiving low-income benefits, or under 20 years old and a dependant of someone receiving low-income benefits.

Support is also available through the NHS Low Income Scheme for those patients who are not eligible for an exemption or for full remission of dental patient charges. Further information is available at the following link:

https://www.nhs.uk/nhs-services/dentists/who-is-entitled-to-free-nhs-dental-treatment-in-england/

It is the patient’s responsibility to check their eligibility for exemptions from dental patient charges and to help with health costs. The Department has provided information to dental practices on signposting patients to the NHS Business Services Authority’s resources on dental patient charges. This includes the ‘Check before you Tick’ website which provides an immediate way to check eligibility for free dental treatment. Further information is available at the following link:

https://www.nhsbsa.nhs.uk/dont-get-caught-out-penalty-charges/check-you-tick

There are no current plans to expand Real Time Exemption Checking beyond the pharmacy setting.

Everyone who has been diagnosed with diabetes is eligible for a free National Health Service eye test, as there is a higher prevalence of some eye conditions amongst people with diabetes. In addition, due to the risk of diabetic retinopathy, all people with diabetes, aged 12 years old and over, are offered Diabetic Eye Screening free of charge. It is offered every one or two years, depending on the level of risk. Those with sight-threatening diabetic retinopathy are offered more frequent surveillance.

Ministers and senior Department officials will work with the new executive team at the top of NHS England, led by Sir Jim Mackey, to lead the formation of a new joint centre. As we work to bring the two organisations together, we will ensure that we continue to evaluate impacts of all kinds.

The Government plans to tackle the challenges for patients trying to access National Health Service dental care with a rescue plan to provide 700,000 more urgent dental appointments and recruit new dentists to the areas that need them most.

The responsibility for commissioning primary care, including dentistry, to meet the needs of the local population has been delegated to all integrated care boards across England.

We want a society where every person receives high-quality, compassionate care from diagnosis through to the end of life.

The Government is determined to shift more healthcare out of hospitals and into the community, to ensure patients and their families receive personalised care in the most appropriate setting, and palliative and end of life care services, including hospices, will have a big role to play in that shift.

Whilst the majority of palliative and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people at end of life and their loved ones.

Integrated care boards (ICBs) have a statutory responsibility to commission cost-effective healthcare to meet the needs of their local populations. This includes the arrangement of services for ear wax removal. When ICBs exercise their functions, including commissioning healthcare services such as ear wax removal, they have a duty to reduce inequalities between persons with respect to their ability to access health services, and to reduce inequalities between patients with respect to the outcomes achieved for them by the provision of health services.

Guidance for general practitioners (GPs) on ear wax removal is provided by the National Institute for Health and Care Excellence (NICE). Manual ear syringing is no longer advised by the NICE due to the risks associated with it, such as trauma to their ear drum or infection, so GPs will often recommend home treatment remedies to alleviate ear wax build-up.

However, in line with the NICE’s guidance, a person may require ear wax removal treatment if the build-up of earwax is linked with hearing loss. A GP could then consider referring the patient into audiology services, which ICBs are responsible for commissioning.

Integrated care boards (ICBs) have a statutory responsibility to commission cost-effective healthcare to meet the needs of their local populations. This includes the arrangement of services for ear wax removal. When ICBs exercise their functions, including commissioning healthcare services such as ear wax removal, they have a duty to reduce inequalities between persons with respect to their ability to access health services, and to reduce inequalities between patients with respect to the outcomes achieved for them by the provision of health services.

Guidance for general practitioners (GPs) on ear wax removal is provided by the National Institute for Health and Care Excellence (NICE). Manual ear syringing is no longer advised by the NICE due to the risks associated with it, such as trauma to their ear drum or infection, so GPs will often recommend home treatment remedies to alleviate ear wax build-up.

However, in line with the NICE’s guidance, a person may require ear wax removal treatment if the build-up of earwax is linked with hearing loss. A GP could then consider referring the patient into audiology services, which ICBs are responsible for commissioning.

NHS England published a range of documents to support the commissioning of sight testing in special educational settings on 25 March 2025, and integrated care boards will now be in the process of planning to procure local services. The scale of the roll out will be dependent on educational establishments choosing to host a service.

There are currently 22 proof-of-concept contractors continuing to deliver the sight testing and dispensing service in 83 day and residential special schools. Data on the number of practitioners delivering the National Health Service special schools eye care service within those contracts is not held centrally.

NHS England published a range of documents to support the commissioning of sight testing in special educational settings on 25 March 2025, and integrated care boards will now be in the process of planning to procure local services. The scale of the roll out will be dependent on educational establishments choosing to host a service.

There are currently 22 proof-of-concept contractors continuing to deliver the sight testing and dispensing service in 83 day and residential special schools. Data on the number of practitioners delivering the National Health Service special schools eye care service within those contracts is not held centrally.

The Government understands that more needs to be done to improve outcomes for all people with prostate cancer, including for black men.

NHS England runs Help Us Help You campaigns in England to increase knowledge of cancer symptoms and address barriers to acting on them, to encourage people to come forward as soon as possible to see their general practitioner. The campaigns focus on a range of symptoms, as well as encouraging body awareness, to help people spot symptoms across a wide range of cancers at an earlier point. These campaigns are developed and tailored to reach and resonate with people who are more likely to experience health inequalities, such as black people. Cancer alliances across the country are engaging with their local communities to deliver campaigns, community engagement, and partnership activity to increase symptom knowledge and encourage earlier presentation.

To address disparities and find ways to better detect prostate cancer earlier, we have invested £16 million in the United Kingdom-wide TRANSFORM trial, aimed at helping find the best ways of detecting prostate cancer in men, even if they are not displaying any symptoms. This research will aim to address some of the inequalities that exist in prostate cancer diagnosis by targeting black men in trial recruitment, ensuring that one in ten participants are black men. This is vital as previous trials have not included enough black men to adequately demonstrate the harms and benefits of screening for this group specifically, despite their significantly higher risk.

In addition, following publication of the 10-Year Health Plan, we will develop a new National Cancer Plan. The plan will seek to improve outcomes and address disparities for people diagnosed with cancer, including for prostate cancer. A call for evidence, seeking contributions from individuals and organisations, including ideas on how to improve outcomes for prostate cancer, is available on the GOV.UK website, in an online only format.

The budgets of devolved nations are primarily funded through block grants from the Government, with annual changes determined by the Barnett formula, which aims to allocate funding based on population and the extent of devolved services.

Any saving from the decision to bring NHS England and the Department together to form a joint centre will be reinvested in frontline services within the National Health Service. The formation of a new joint centre will not impact on the Barnett formula, and the finances of the devolved nations.

We will improve National Health Service cancer waiting time performance, so patients are diagnosed and treated faster. We will also improve cancer survival rates by diagnosing cancers at an earlier stage.

We will build on recent successes, including the roll out of the Lung Screening programme, to diagnose cancer earlier and boost survival rates.

Furthermore, the recently announced National Cancer Plan will set out key goals and actions to improve on cancer waiting time performance and survival rates.

The Department supports the NHS in reviewing opportunities to utilise artificial intelligence to transform performance, bring down waiting times, and improve survival rates.